Control costs, increase efficiency and accelerate your clinical programs with our globally integrated bioanalytical solutions
Effective drug development requires accurate testing, specialized support and precise results. From preclinical to early and late clinical phases, we provide comprehensive bioanalytical solutions for your drug development.
With over 30 years of experience, operating out of our GLP/GCP compliant laboratories, we provide expertise to develop assays from scratch. We also support large-scale routine sample analyses – from regulatory pre-clinical (toxicology) to early and late clinical studies (Phase I to IV). We have also recently gained enhanced testing capabilities with advanced ELISA equipment and the Gyrolab xPlore system.
